Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBIO
āļāļ·āđāļāļāļĢāļīāļĐāļąāļBio Rad Laboratories Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMar 17, 1980
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ1975
āļāļĩāļāļĩāđāļMr. Norman D. Schwartz
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ7700
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMar 17
āļāļĩāđāļāļĒāļđāđ1000 Alfred Nobel Dr
āđāļĄāļ·āļāļHERCULES
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNYSE Consolidated
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ94547
āđāļāļĢāļĻāļąāļāļāđ15107247000
āđāļ§āđāļāđāļāļāđhttps://www.bio-rad.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļBIO
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMar 17, 1980
āļāđāļāļāļąāđāļāđāļĄāļ·āđāļ1975
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
Mr. Michael Crowley
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
Mr. Arnold A. Pinkston
Independent Director
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
Ms. Melinda Litherland
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
Mr. Michael Crowley
Executive Vice President - Global Commercial Operations
Executive Vice President - Global Commercial Operations
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
Mr. Arnold A. Pinkston
Independent Director
Parnassus Value Select ETF
VanEck Morningstar ESG Moat ETF
First Trust Indxx Medical Devices ETF
Alger Russell Innovation ETF
ROBO Global Healthcare Technology & Innovation ETF
VanEck Morningstar Wide Moat Growth ETF
Schwab Ariel Opportunities ETF
Pacer US Export Leaders ETF
First Eagle Global Equity ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Parnassus Value Select ETF
āļŠāļąāļāļŠāđāļ§āļ2.78%
VanEck Morningstar ESG Moat ETF
āļŠāļąāļāļŠāđāļ§āļ2.29%
First Trust Indxx Medical Devices ETF
āļŠāļąāļāļŠāđāļ§āļ1.89%
Alger Russell Innovation ETF
āļŠāļąāļāļŠāđāļ§āļ1.78%
ROBO Global Healthcare Technology & Innovation ETF
āļŠāļąāļāļŠāđāļ§āļ1.57%
VanEck Morningstar Wide Moat Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.16%
Schwab Ariel Opportunities ETF
āļŠāļąāļāļŠāđāļ§āļ1.14%
Pacer US Export Leaders ETF
āļŠāļąāļāļŠāđāļ§āļ1.02%
FPA Global Equity ETF
āļŠāļąāļāļŠāđāļ§āļ1.01%
First Eagle Global Equity ETF
āļŠāļąāļāļŠāđāļ§āļ0.84%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ